Preclinical model and histopathology translational medicine and renal denervation

Kenichi Sakakura, Elena Ladich, Fumiyuki Otsuka, Kazuyuki Yahagi, Frank D. Kolodgie, Michael Joner, Renu Virmani

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The prevalence of resistant hypertension, which is defined as failure to achieve control of blood pressure (BP) (<140/90) despite treatment with optimal doses of three or more antihypertensive medications (including diuretics), is as high as 12-15 % of all hypertensive patients. Renal sympathetic denervation is a new treatment option for resistant hypertension. Catheter-radiofrequency renal denervation has demonstrated its efficacy and safety in the SYMPLICITY I, SYMPLICITY II and EnligHTN trials. However, there are still many unanswered questions in this field, and preclinical studies using animal models may help researchers and clinicians to find answers to those questions. Generally, larger animals such as pig, dog, or sheep are needed for the preclinical study. The swine model is frequently used for the preclinical study, since the anatomy of renovascular system is similar to that of humans. A semi-quantitative ordinal grading system is useful, when the changes of nerves, renal artery, and peri-arterial soft tissue induced by renal denervation are evaluated.

Original languageEnglish
Title of host publicationRenal Denervation
Subtitle of host publicationA New Approach to Treatment of Resistant Hypertension
PublisherSpringer-Verlag London Ltd
Pages15-24
Number of pages10
ISBN (Electronic)9781447152231
ISBN (Print)9781447152224
DOIs
StatePublished - 1 Jan 2015
Externally publishedYes

Fingerprint

Dive into the research topics of 'Preclinical model and histopathology translational medicine and renal denervation'. Together they form a unique fingerprint.

Cite this